NPPA and nephrotic syndrome: The authors concluded that D1 receptors may play a major role in ANP resistance observed in PAN-nephrotic syndrome, since coadministration of SCH-23390 (a D1 receptor antagonist) abolished the effects elicited by zaprinast [51].